IN2013MU02133A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02133A
IN2013MU02133A IN2133MU2013A IN2013MU02133A IN 2013MU02133 A IN2013MU02133 A IN 2013MU02133A IN 2133MU2013 A IN2133MU2013 A IN 2133MU2013A IN 2013MU02133 A IN2013MU02133 A IN 2013MU02133A
Authority
IN
India
Prior art keywords
acetoxyandrosta
diene
pharmaceutically acceptable
acceptable salt
abiraterone acetate
Prior art date
Application number
Other languages
English (en)
Inventor
Rajamannar Thennati
Rajeev Budhdev Rehani
Nischalkumar Vinodbhai Patel
Riteshkumar Rajnikant Kansara
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Priority to EP14816900.6A priority Critical patent/EP3013844A4/en
Priority to IN2133MU2013 priority patent/IN2013MU02133A/en
Priority to US14/392,210 priority patent/US20160176915A1/en
Priority to PCT/IN2014/000420 priority patent/WO2014207762A1/en
Priority to JP2016522965A priority patent/JP2016527213A/ja
Publication of IN2013MU02133A publication Critical patent/IN2013MU02133A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IN2133MU2013 2013-06-24 2014-06-24 IN2013MU02133A (enrdf_load_stackoverflow)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP14816900.6A EP3013844A4 (en) 2013-06-24 2014-06-24 Process for preparation of abiraterone acetate
IN2133MU2013 IN2013MU02133A (enrdf_load_stackoverflow) 2013-06-24 2014-06-24
US14/392,210 US20160176915A1 (en) 2013-06-24 2014-06-24 Process for preparation of abiraterone acetate
PCT/IN2014/000420 WO2014207762A1 (en) 2013-06-24 2014-06-24 Process for preparation of abiraterone acetate
JP2016522965A JP2016527213A (ja) 2013-06-24 2014-06-24 アビラテロン酢酸エステルの製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2133MU2013 IN2013MU02133A (enrdf_load_stackoverflow) 2013-06-24 2014-06-24

Publications (1)

Publication Number Publication Date
IN2013MU02133A true IN2013MU02133A (enrdf_load_stackoverflow) 2015-06-05

Family

ID=52141189

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2133MU2013 IN2013MU02133A (enrdf_load_stackoverflow) 2013-06-24 2014-06-24

Country Status (5)

Country Link
US (1) US20160176915A1 (enrdf_load_stackoverflow)
EP (1) EP3013844A4 (enrdf_load_stackoverflow)
JP (1) JP2016527213A (enrdf_load_stackoverflow)
IN (1) IN2013MU02133A (enrdf_load_stackoverflow)
WO (1) WO2014207762A1 (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108948120A (zh) * 2018-07-07 2018-12-07 张正光 一种醋酸阿比特龙中间体的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2265624B (en) * 1992-03-31 1995-04-19 British Tech Group 17-substituted steroids useful in cancer treatment
DK2428519T3 (en) * 2004-08-24 2015-04-13 Btg Int Ltd A composition for the preparation of 17-vinyl triflates as intermediates
GB0418900D0 (en) * 2004-08-24 2004-09-29 Btg Int Ltd Novel salt forms
WO2014071983A1 (en) * 2012-11-09 2014-05-15 Synthon Bv Process for making the 17-triflate intermediate of abiraterone-3-acetate
EP2917225A1 (en) * 2012-11-09 2015-09-16 Synthon BV Process for making abiraterone-3-acetate
ES2581317T3 (es) * 2013-07-29 2016-09-05 Industriale Chimica S.R.L. Proceso de preparación de abiraterona o acetato de abiraterona
US9650410B2 (en) * 2013-07-29 2017-05-16 Industriale Chimica S.R.L. Process for the preparation of abiraterone and abiraterone acetate

Also Published As

Publication number Publication date
US20160176915A1 (en) 2016-06-23
EP3013844A4 (en) 2017-03-01
JP2016527213A (ja) 2016-09-08
WO2014207762A1 (en) 2014-12-31
EP3013844A1 (en) 2016-05-04

Similar Documents

Publication Publication Date Title
IN2015KN00262A (enrdf_load_stackoverflow)
WO2011119004A3 (en) Method of producing d-psicose crystals
WO2014072961A3 (en) Polymorphic forms of suvoroxant
EP2970083A4 (en) Process to prepare levulinic acid
WO2012015999A3 (en) Process for the preparation of imatinib mesylate
EP2999688A4 (en) Process to prepare levulinic acid
IL241038A0 (en) A new salt of abacinostat, a related crystalline form, a method for their preparation and pharmaceutical preparations containing them
WO2013128379A3 (en) Crystalline polymorphic forms of linagliptin
WO2015102022A3 (en) An improved process for the preparation of abiraterone acetate
HK1221645A1 (zh) Vmat2的苯並喹啉抑制劑
EP4289819A3 (en) Process for the preparation of enantiomerically enriched 3-aminopiperidine
UY33511A (es) Procedimiento de obtención de la forma cristalina ii del febuxostat
HK1223300A1 (zh) 皮质类固醇组合物
WO2014141294A3 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
HK1212978A1 (zh) 芥子酸的新型衍生物
WO2014118606A3 (en) A novel process for the preparation of silodosin
WO2013072938A3 (en) Process for the preparation of roflumilast
IL245260B (en) Non-aqueous crystalline form of cabazitaxel, process for its preparation and pharmaceutical compositions thereof
WO2015087343A3 (en) An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof
IN2013MU02133A (enrdf_load_stackoverflow)
WO2014195977A3 (en) Novel polymorphs of vismodegib
WO2013046233A3 (en) Process for the preparation of octreotide acetate
WO2012159981A3 (en) PROCESS FOR THE PREPARATION OF α-SUBSTITUTED KETONES AND THEIR APPLICATION IN SYNTHESIS OF PHARMACEUTICALLY ACTIVE COMPOUNDS
UY33510A (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
IN2013MU03508A (enrdf_load_stackoverflow)